Since its introduction, CRISPR has become a core genome editing tool that has transformed biological research. First-generation CRISPR technologies were limited in scalability, accessibility, edit variety, and ease of use, restricting their potential. Inscripta’s Onyx™ platform addresses these limitations by combining easy-to-use, intuitive software with a push-button automated benchtop device, enabling high-efficiency, massively-parallel, precision-engineered edits to Saccharomyces cerevisiae and Escherichia coli genomes. In this webinar brought to you by Inscripta, Tyson Shepherd will present applications in E. coli that leverage this platform. He will show how a library totaling more than 25,000 different designs and a separate library of 900 designs yielded new biochemical insights underpinning tolerance to a panel of growth-inhibitory compounds. These applications demonstrate the power of the Onyx™ platform to usher in a new era of genome editing.
Topics to be covered
Highly efficient, massively-parallel CRISPR edited E. coli library generation
Genetic insights into bacterial growth inhibitor tolerance from large scale libraries
Tuesday, March 30, 2021
11:00 AM - 12:00 PM Eastern Time
Meet the speaker
Tyson Shepherd, PhD Microbial Applications Specialist Inscripta, Inc.
Understanding Immune-Mediated Damage After Respiratory Infection March 16, 2021
Information you provide will be shared with the sponsors for this content. The Scientist or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
The Scientist c/o LabX Media Group 1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801 Toll Free: 888.788.0328 | Phone: 705.528.6888 Email: email@example.com